Treatment of Shingles (Herpes Zoster)
Start oral antiviral therapy immediately—ideally within 72 hours of rash onset—with valacyclovir 1g three times daily for 7 days, acyclovir 800mg five times daily for 7-10 days, or famciclovir 500mg three times daily for 7 days to reduce acute pain duration and prevent postherpetic neuralgia. 1, 2, 3
Antiviral Therapy: The Cornerstone of Treatment
The primary goal is to initiate systemic antiviral medication as rapidly as possible:
Timing is critical: Maximum benefit occurs when treatment begins within 72 hours of rash appearance, though some benefit may still occur if started later, particularly in high-risk patients 1, 2, 3
First-line antiviral options (all are effective; choice depends on dosing convenience and patient preference):
Valacyclovir and famciclovir offer superior bioavailability compared to acyclovir, allowing for less frequent dosing and potentially better patient adherence 1, 3
Pain Management
Adequate analgesia is essential alongside antiviral therapy:
Acute pain control: Use acetaminophen, NSAIDs, or opioid analgesics as needed based on pain severity 1, 3
Neuropathic pain agents: Consider gabapentin or pregabalin early if neuropathic pain characteristics are present 1, 3
Avoid routine corticosteroids: While older guidelines suggested potential benefit, current evidence does not support routine corticosteroid use in acute herpes zoster due to limited efficacy and potential adverse effects 2, 3
Special Populations Requiring Modified Approach
Immunocompromised patients (HIV infection, transplant recipients, chemotherapy, chronic corticosteroids):
- Consider higher doses of acyclovir (800mg five times daily) or standard doses of valacyclovir/famciclovir 1, 3
- Monitor closely for treatment failure or disseminated disease 1
- Intravenous acyclovir (10mg/kg every 8 hours) is indicated for severe disease, disseminated infection, or visceral involvement 3
Ophthalmic involvement (herpes zoster ophthalmicus):
- Requires urgent ophthalmology referral in addition to systemic antivirals 1, 3
- Risk of vision-threatening complications necessitates specialist co-management 3
Local Therapy
- Topical measures: Cool compresses, calamine lotion, or colloidal oatmeal baths for symptomatic relief 1, 3
- Avoid topical antivirals: They are substantially less effective than systemic therapy and should not be used 1
Common Pitfalls to Avoid
- Do not delay treatment waiting for laboratory confirmation—diagnosis is clinical, and early treatment is paramount 1, 2
- Do not prescribe tricyclic antidepressants in the acute phase—they are ineffective for acute pain and reserved for established postherpetic neuralgia 2
- Do not use topical acyclovir—it provides minimal benefit compared to oral formulations 1
- Do not assume age restrictions—while shingles is more common in older adults, it can occur in children and younger adults, particularly those with risk factors 4
Prevention Counseling
After treating acute shingles, discuss vaccination to prevent future episodes:
- Recombinant zoster vaccine (Shingrix) is recommended for adults ≥50 years and immunocompromised adults ≥18 years 5, 6
- Two-dose series administered 2-6 months apart (can be shortened to 1-2 months in immunocompromised patients) 5, 6
- Markedly reduces incidence of both herpes zoster and postherpetic neuralgia 5, 2